Filing Details
- Accession Number:
- 0001209191-20-048107
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-24 16:56:06
- Reporting Period:
- 2020-08-20
- Accepted Time:
- 2020-08-24 16:56:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1468748 | Kodiak Sciences Inc. | KOD | Biological Products, (No Disgnostic Substances) (2836) | 270476525 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754049 | Jason Ehrlich | 2631 Hanover Street Palo Alto CA 94304 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-20 | 6,950 | $10.29 | 40,934 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-20 | 2,591 | $46.42 | 38,343 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-20 | 4,359 | $47.53 | 33,984 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-20 | 6,950 | $0.00 | 6,950 | $10.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 379,525 | 2028-08-29 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $46.00 to $46.93, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $47.05 to $47.66, inclusive.
- Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
Billionaire Hedge Funds
